Search Login Register

rivastigmine (Exelon) Summary

Also Known As: Exelon; (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate; ENA 713; ENA-713; SDZ ENA 713 Show All >>

Networked: 701 relevant articles (121 outcomes, 220 trials/studies) for this Drug

Key Diseases for which rivastigmine is Relevant

  1. Alzheimer Disease (Alzheimer's Disease) : 68 outcomes 115 studies in 438 results
  2. Dementia (Dementias) : 41 outcomes 58 studies in 226 results
  3. Parkinson Disease (Parkinson's Disease) : 13 outcomes 17 studies in 72 results
  4. Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) : 6 outcomes 11 studies in 23 results
  5. Schizophrenia (Dementia Praecox) : 4 outcomes 10 studies in 17 results
Show All >>

Drugs Related to rivastigmine

  1. donepezil (Aricept)
  2. Galantamine (Galanthamine)
  3. Cholinesterase Inhibitors (Anticholinesterases)
  4. Memantine (Namenda)
  5. Cholinesterases (Cholinesterase)
  6. rivastigmine (Exelon)
  7. Tacrine (Cognex)
  8. Trichlorfon (Metrifonate)
  9. Ginkgo biloba extract 761 (Rokan)
  10. Acetylcholinesterase
Show All >>

Therapies Related to rivastigmine

  1. Transdermal Patch
  2. Activities of Daily Living (ADL)
  3. Home Nursing (Nursing, Home)
  4. Cutaneous Administration
  5. Drug Therapy (Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.